SEC Form 4 · accession 0001387131-15-000126
Ohr Pharmaceutical Inc · OHRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ira A Greenstein
Director
Period of report
Jan 15, 2015
Accepted (ET)
Jan 16, 2015 · 2:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001173281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 15, 2015 | X | 54,659 | $1.65 | A | 431,051 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF3,F4 | $1.65 | Jan 15, 2015 | X | 66,667 | D | Jan 15, 2010 | Jan 15, 2015 | Common Stock | 66,667 | 100,000 | D |
Explanation of responses
- F1The common stock was acquired by converting warrants held by Mr. Ira Greenstein using cashless exercise.
- F2Includes options and warrants, some of which are not exercisable.
- F3The warrants were converted using cashless exercise.
- F4Includes options and warrants not currently exercisable.